CardioDx, Inc. to Present at the 11th Annual Needham Healthcare Conference

PALO ALTO, Calif.--(BUSINESS WIRE)--CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced that Chief Medical Officer Mark Monane, M.D., will present an overview of the company and of Corus®CAD, the first and only clinically validated gene expression test for obstructive coronary artery disease, at the 11th Annual Needham Healthcare Conference on Tuesday, April 3 at 10:40 a.m. ET at the New York Palace Hotel.